文献速递浆细胞疾病

质谱检测的MGUS在高危人群中与肥胖及其他新型可改变危险因素相关

Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population.
PubMed 文献 · Blood Adv · 2024-01-01

PROMISE试验纳入2628例多发性骨髓瘤高危个体,用质谱筛查单克隆蛋白(≥0.2 g/L定义为MS-MGUS)并分析暴露因素。肥胖与MS-MGUS相关(OR 1.73,95%CI 1.21-2.47,P=.003),高体力活动降低风险,重度吸烟和短睡眠增加风险。

要点

  • 肥胖(BMI≥30 kg/m2)与质谱检测的MGUS相关,OR 1.73(95%CI 1.21-2.47,P=.003)。
  • 高体力活动(≥73.5 MET-小时/周)与MS-MGUS风险降低相关,OR 0.45(95%CI 0.24-0.80,P=.009)。
  • 重度吸烟(>30包年)和短睡眠(<6小时/天)与MS-MGUS风险升高相关。

核心结论

  • 质谱检测的单克隆丙种球蛋白病与比既往已知更广泛的可改变危险因素相关。

研究设计与样本

  • PROMISE试验为筛查研究,纳入2628例多发性骨髓瘤高危个体并完成暴露调查。
  • 参与者样本经质谱筛查,单克隆蛋白浓度≥0.2 g/L归类为MS-MGUS。
  • 采用多变量逻辑回归模型评估暴露与MS结局的关联。

主要发现

  • 与正常体重(BMI 18.5至<25 kg/m2)相比,肥胖(BMI≥30 kg/m2)与MS-MGUS相关,校正年龄、性别、黑人种族、教育和收入后OR 1.73(95%CI 1.21-2.47,P=.003)。
  • 高体力活动(≥73.5 MET-小时/周 vs <10.5 MET-小时/周)与MS-MGUS可能性降低相关,OR 0.45(95%CI 0.24-0.80,P=.009)。
  • 重度吸烟(>30包年 vs 从不吸烟)与MS-MGUS可能性升高相关,OR 2.19(95%CI 1.24-3.74,P=.005)。
  • 短睡眠(<6 vs ≥6小时/天)与MS-MGUS可能性升高相关,OR 2.11(95%CI 1.26-3.42,P=.003)。
  • 在所有质谱检测的单克隆丙种球蛋白病(含M蛋白浓度<0.2 g/L)分析中,BMI升高和吸烟与所有MS阳性病例相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant condition of multiple myeloma with few known risk factors. The emergence of mass spectrometry (MS) for the detection of MGUS has provided new opportunities to evaluate its risk factors. In total, 2628 individuals at elevated risk for multiple myeloma were enrolled in a screening study and completed an exposure survey (PROMISE trial). Participant samples were screened by MS, and monoclonal proteins (M-proteins) with concentrations of ≥0.2 g/L were categorized as MS-MGUS. Multivariable logistic models evaluated associations between exposures and MS outcomes. Compared with normal weight (body mass index [BMI] of 18.5 to <25 kg/m2), obesity (BMI of ≥30 kg/m2) was associated with MS-MGUS, adjusting for age, sex, Black race, education, and income (odds ratio [OR], 1.73; 95% confidence interval [CI], 1.21-2.47; P = .003). High physical activity (≥73.5 metabolic equivalent of task (MET)-hours per week vs <10.5 MET-hours per week) had a decreased likelihood of MS-MGUS (OR, 0.45, 95% CI, 0.24-0.80; P = .009), whereas heavy smoking and short sleep had increased likelihood of MS-MGUS (>30 pack-years vs never smoker: OR, 2.19; 95% CI, 1.24-3.74; P = .005, and sleep <6 vs ≥6 hours per day: OR, 2.11; 95% CI, 1.26-3.42; P = .003). In the analysis of all MS-detected monoclonal gammopathies, which are inclusive of M-proteins with concentrations of <0.2 g/L, elevated BMI and smoking were associated with all MS-positive cases. Findings suggest MS-detected monoclonal gammopathies are associated with a broader range of modifiable risk factors than what has been previously identified. This trial was registered at www.clinicaltrials.gov as #NCT03689595.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lee DJ, El-Khoury H, Tramontano AC, et al. Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population. Blood Adv. 2024. PMID: 38212245. doi:10.1182/bloodadvances.2023010843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。